Failure to Act on Pharmacist's Recommendation for Gradual Dose Reduction
Summary
The facility failed to ensure that licensed nurses acted upon the Pharmacists' Consultation Report by notifying Resident 20's physician about the pharmacist's recommendation to attempt a gradual dose reduction (GDR) of Escitalopram Oxalate, a medication used to treat depression. Resident 20, who had diagnoses including diabetes mellitus, end-stage renal disease, and depression, was receiving Escitalopram Oxalate 5 mg daily. The Minimum Data Set (MDS) indicated that Resident 20 had intact cognition and was receiving both antianxiety and antidepressant medications during the assessment period. Despite the pharmacist's recommendation for a GDR on 2/5/2024, no action was taken, and the physician's response to the recommendation was not documented, as confirmed by the Director of Nursing (DON) during an interview and record review on 4/7/2024. The facility's policy and procedure required that the consultant pharmacist's recommendations be acted upon within a reasonable timeframe, but this was not followed in Resident 20's case. The failure to act on the pharmacist's recommendation resulted in the recommended GDR not being performed for Resident 20, which had the potential to place other residents receiving antidepressant medications at risk for unnecessary medication use. The facility's policies, including the Medication Regimen Review and Reporting policy and the Consultant Pharmacist Reports policy, emphasized the importance of acting on and documenting the consultant pharmacist's recommendations to prevent or minimize adverse consequences related to medication therapy. However, these policies were not adhered to, leading to the deficiency noted in the report.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.